老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Iovance Biotherapeutics, Inc.

14.37
-0.1950-1.34%
成交量：187.27万
成交额：2,717.65万
市值：65.07亿
市盈率：-20.35
高：14.68
开：14.48
低：14.32
收：14.56
52周最高：15.30
52周最低：1.76
股本：4.53亿
流通股本：3.94亿
量比：0.79
换手率：0.48%
股息：- -
股息率：- -
每股收益(TTM):-0.7058
每股收益(LYR):-1.0941
净资产收益率：-40.36%
总资产收益率：-20.31%
市净率：8.84
市盈率(LYR):-13.13

数据加载中...

总览公司新闻资讯公告
2019/07/19

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/02

重要事件披露

Current report, items 8.01 and 9.01
2019/06/21

重要事件披露

Current report, items 1.01 and 9.01
2019/06/11

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/11

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/11

持股变动声明

Initial statement of beneficial ownership of securities
2019/06/11

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/11

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/11

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/11

重要事件披露

Current report, items 5.02, 5.03, 5.07, 8.01, and 9.01
2019/06/03

重要事件披露

Current report, items 1.01, 8.01, and 9.01
2019/05/22

重要事件披露

Current report, items 8.01 and 9.01
2019/05/16

重要事件披露

Current report, items 8.01 and 9.01
2019/05/07

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/05/07

重要事件披露

Current report, items 2.02 and 9.01
2018/12/07

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2018/10/01

SEC问询函

[Cover]Correspondence
2018/09/07

员工持股计划

Securities to be offered to employees in employee benefit plans, post-effective amendments
2018/01/17

SEC问询函

2017/07/31

员工持股计划

更多